US 6569459
Method of administration of paclitaxel-plasma protein formulation
expired A61KA61K47/42A61K9/0019
Quick answer
US patent 6569459 (Method of administration of paclitaxel-plasma protein formulation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/42, A61K9/0019